Startseite>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>Haloperidol

Haloperidol (Synonyms: McNJR 1625, NSC 170973, NSC 615296, R 1625)

Katalog-Nr.GC17599

Haloperidol ist ein starker Dopamin-D2-Rezeptorantagonist, der weithin als Antipsychotikum verwendet wird.

Products are for research use only. Not for human use. We do not sell to patients.

Haloperidol Chemische Struktur

Cas No.: 52-86-8

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
37,00 $
Auf Lager
500mg
55,00 $
Auf Lager
1g
103,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

Haloperidol is an antipsychotic drug that has similar actions to the antipsychotic medicine phenothiazine [1].

Haloperidol has been reported to play a role as an inverse agonist of dopamine. In addition, Haloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function. Besides, Haloperidol has shown about 50-fold potency than chiorpromazine, the other antipsychotic drug. Haloperidol has shown beneficial effects in the treatment of delusions and hallucinations. These effects are mainly achieved through blockage of dopamine receptors in the mesocortex and limbic system. Haloperidol has been revealed to prevent the effects of dopamine in the nigrostriatal pathways, which probably explains the associated side effects such as akathisia and dystonias[1].

References:
[1] Dr Ananya Mandal, MD .Haloperidol Pharmacology.

Bewertungen

Review for Haloperidol

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Haloperidol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.